News

  • TOP
  • News
  • Participation in the development project of comprehensive evaluation method of COVID-19 virus antigen-specific immune responses for selection of high-risk patients

Participation in the development project of comprehensive evaluation method of COVID-19 virus antigen-specific immune responses for selection of high-risk patients

2020/06/08

Repertoire Genesis Inc. (Headquarters: Ibaraki, Osaka) entered into the project of "Development of comprehensive evaluation method of COVID-19 virus antigen-specific immune responses for selection of high-risk patients" which is conducted by Professor Takashi Shiina of Tokai University as principal investigator.

View original content:Press Release